PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-10-12 (2)

Date Title Company
12-Oct-2023 Sotyktu (deucravacitinib) Long-Term Data Demonstrate Durable Efficacy and Consistent Safety for up to Three Years in Moderate-to-Severe Plaque Psoriasis Businesswire